DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.

MLA

Kerdivel, Gwenneg, et al. “DNA Hypermethylation Driven by DNMT1 and DNMT3A Favors Tumor Immune Escape Contributing to the Aggressiveness of Adrenocortical Carcinoma.” Clinical Epigenetics, vol. 15, no. 1, Aug. 2023, p. 121. EBSCOhost, https://doi.org/10.1186/s13148-023-01534-5.

APA

Kerdivel, G., Amrouche, F., Calmejane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J., Assié, G., & Boeva, V. (2023). DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma. Clinical Epigenetics, 15(1), 121. https://doi.org/10.1186/s13148-023-01534-5

Chicago

Kerdivel, Gwenneg, Floriane Amrouche, Marie-Ange Calmejane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jérôme Bertherat, Guillaume Assié, and Valentina Boeva. 2023. “DNA Hypermethylation Driven by DNMT1 and DNMT3A Favors Tumor Immune Escape Contributing to the Aggressiveness of Adrenocortical Carcinoma.” Clinical Epigenetics 15 (1): 121. doi:10.1186/s13148-023-01534-5.